Engineering immunosuppressive drug-resistant armored (IDRA) SARS-CoV-2 T cells for cell therapy.
Chen Q, Chia A, Hang SK, Lim A, Koh WK, Peng Y, Gao F, Chen J, Ho Z, Wai LE, Kunasegaran K, Tan AT, Le Bert N, Loh CY, Goh YS, Renia L, Dong T, Vathsala A, Bertoletti A.
Chen Q, et al. Among authors: koh wk.
Cell Mol Immunol. 2023 Nov;20(11):1300-1312. doi: 10.1038/s41423-023-01080-3. Epub 2023 Sep 5.
Cell Mol Immunol. 2023.
PMID: 37666955